SAFETY AND EFFICACY OF NOVEL ANTIVIRALS IN KIDNEY TRANSPLANT RECIPIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION

被引：8

作者：

Lin, M. V. ^{[1
]}

Sise, M. E. ^{[2
]}

Pavlakis, M. ^{[3
]}

Hanifi, J. M. ^{[4
]}

Rutherford, A. E. ^{[1
]}

Elias, N. ^{[5
]}

Heher, E. C. ^{[2
]}

Curry, M. P. ^{[6
]}

Riella, L. V. ^{[7
]}

机构：

[1] Brigham & Womens Hosp, Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA

[2] Massachusetts Gen Hosp, Nephrol, Boston, MA 02114 USA

[3] Beth Israel Deaconess Med Ctr, Nephrol, Boston, MA USA

[4] Brigham & Womens Hosp, Internal Med, Boston, MA 02115 USA

[5] Massachusetts Gen Hosp, Transplant Surg, Boston, MA 02114 USA

[6] Beth Israel Deaconess Med Ctr, Gastroenterol Liver Ctr, Boston, MA USA

[7] Brigham & Womens Hosp, Nephrol, Boston, MA 02115 USA

来源：

关键词：

D O I：

10.1016/S0168-8278(15)30196-3

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LP42

引用

页码：S284 / S285

页数：2